MSD India Enlists Madhuri Dixit For Cervical Cancer Awareness
08 May 2026 //
ECONOMICTIMES
Merck Scientists Publish Paper on Oral PCSK9 Inhibitor Synthesis
07 May 2026 //
PHARMIWEB
Merck Completes Acquisition Of Terns Pharmaceuticals
05 May 2026 //
PHARMIWEB
KEYTRUDA SC Subcutaneous Form Now Available Across UK
04 May 2026 //
FIRSTWORD PHARMA
Merck & Co.`s Keytruda posts $8B in Q1 as Qlex picks up steam
01 May 2026 //
FIRSTWORD PHARMA
Merck Halts TROP ADC Development as Keytruda Clock Ticks
30 Apr 2026 //
BIOSPACE
Merck`s Playing With Heart Program Partners With Baseball Clubs
28 Apr 2026 //
PHARMIWEB
Merck goes with Google for AI push, strikes $1B enterprise deal
25 Apr 2026 //
PR NEWSWIRE
Merck, Rivals Eye Inhibrx Experimental Drug Tied to Keytruda
25 Apr 2026 //
REUTERS
Merck Clears Hart-Scott-Rodino Act for Terns Pharma Acquisition
24 Apr 2026 //
BUSINESSWIRE
Merck’s Welireg Triplet Fails Phase 3 in first-line kidney Cancer
22 Apr 2026 //
FIERCE PHARMA
US FDA approves Merck`s pill combo to treat HIV
22 Apr 2026 //
PRESS RELEASE
Merck, Eisai Update on LITESPARK-012 Phase 3 RCC Trial
21 Apr 2026 //
BUSINESSWIRE
Bioinvent To Showcase BI-1808 And Keytruda In Ovarian Cancer
21 Apr 2026 //
PHARMIWEB
Merck Sharp And Dohme’s Idvynso Receives Approval in US
20 Apr 2026 //
FDA
Merck`s PD-1/VEGF Data Shine in Stacked AACR `26 Lineup
17 Apr 2026 //
BIOSPACE
EU Approves Merck`s ENFLONSIA for Infant RSV Prevention
17 Apr 2026 //
PHARMIWEB
Merck unveils PD-1xVEGF bispecific data in NSCLC
17 Apr 2026 //
FIERCE BIOTECH
Aurobindo`s Theranym Invests $175M In Expanded Biologics Deal
16 Apr 2026 //
INDPHARMAPOST
Merck India, MAHE Launch Catalyst Program For Future R&D Talent
13 Apr 2026 //
INDPHARMAPOST
Merck Expands Bengaluru Facility For Global Filtration Device
09 Apr 2026 //
EXPRESSPHARMA
Merck, Zhifei Rework Their China Vaccine Distribution Agreement
07 Apr 2026 //
FIERCE PHARMA
Merck Begins Tender Offer To Acquire Terns Pharmaceuticals
07 Apr 2026 //
PHARMIWEB
ACOFP Gathers Experts at Chronic Disease Summit
06 Apr 2026 //
PHARMIWEB
Merck Starts Phase 2b/3 Trial of MK-8748 for Wet AMD
02 Apr 2026 //
PHARMIWEB
EC Approve KEYTRUDA + Paclitaxel ± Bevacizumab for Ovarian Cancer
02 Apr 2026 //
PHARMIWEB
Merck Completes Acquisition of JSR Life Sciences Chromatography
01 Apr 2026 //
INDPHARMAPOST
Merck Schedules Q1 2026 Earnings Call for April 30
01 Apr 2026 //
PHARMIWEB
Merck Enlists Antibody Hunter Infinimmune For $838M Biobucks
31 Mar 2026 //
FIERCE BIOTECH
Merck`s cholesterol drug meets main goal in head-to-head trial
31 Mar 2026 //
REUTERS
Merck Advances Winrevair To Pivotal Study Despite Dose Concerns
30 Mar 2026 //
BIOSPACE
WINREVAIR Shows Ph2 Proof In PH-HFpEF Patients
29 Mar 2026 //
BUSINESSWIRE
Merck to Acquire Terns Pharmaceuticals
25 Mar 2026 //
PRESS RELEASE
Quotient Therapeutics, Merck Partner on IBD Targets
24 Mar 2026 //
GLOBENEWSWIRE
FDA Approves BRAVECTO® QUANTUM from Merck Animal Health
18 Mar 2026 //
PHARMIWEB
Merck Presents Gardasil Data At EUROGIN HPV Congress
17 Mar 2026 //
BUSSINESSWIRE
Keytruda Hangs On To Best Seller Crown As Glp-1s Gain Ground
04 Mar 2026 //
BIOSPACE
Tempus, Merck Partner To Advance AI Precision Medicine
03 Mar 2026 //
BUSINESSWIRE
Merck, Pfizer`s Bladder Cancer Drug Combo Redefines Standard
02 Mar 2026 //
BIOSPACE
Keytruda + Welireg Cuts RCC Recurrence 28% VS Placebo
28 Feb 2026 //
BUSINESSWIRE
Merck`s Welireg combos deliver 1-2 punch to kidney cancer
28 Feb 2026 //
FIERCE PHARMA
Padcev-Keytruda Combo Wins in MIBC Amid Evolving Landscape
28 Feb 2026 //
FIERCE PHARMA
Keytruda Combo Improves OS in Platinum-Resistant Ovarian Cancer
27 Feb 2026 //
BUSINESSWIRE
Merck, Working Through Gardasil Demand Woes, Cuts Jobs In NC
27 Feb 2026 //
FIERCE PHARMA
Synthekine, Merck Launch STK-012/Keytruda Trial for NSCLC Cancer
26 Feb 2026 //
BUSINESSWIRE
MSD appoints Brecht Vanneste as MD for India
26 Feb 2026 //
EXPRESSPHARMA
Gilead, Merck Clear Path for Daily HIV Pills with Late-Stage Data
26 Feb 2026 //
BIOSPACE
FDA Greenlights NUMELVI For Canine Allergic Dermatitis By Merck
25 Feb 2026 //
BUSINESSWIRE
Merck Shares Late-Breaking Ph 3 DOR/ISL Data at CROI 2026
25 Feb 2026 //
BUSINESSWIRE
Merck Joins TD Cowen 46th Health Care Conference
24 Feb 2026 //
PHARMIWEB
Merck Restructures To Enhance Human Health Portfolio Execution
23 Feb 2026 //
PHARMIWEB
Merck Reorganizes Human Health Work Into Two New Units
23 Feb 2026 //
BIOSPACE
Merck Shows Positive ENFLONSIA Data for High-Risk Infants
19 Feb 2026 //
PHARMIWEB
Merck, Mayo Clinic Launch AI Precision Medicine R&D Collaboration
18 Feb 2026 //
BUSINESSWIRE
Merck to Present New Bladder, Kidney Cancer Data at 2026 ASCO
12 Feb 2026 //
BUSINESSWIRE
Keytruda Combo Approved for Platinum-Resistant Ovarian Cancer
12 Feb 2026 //
FDA
Merck Teams Up With British Medtech Calla Lily
10 Feb 2026 //
FIERCE BIOTECH
Immutep Reaches 50% Enrollment In Global Phase III Trial For 1L
06 Feb 2026 //
GLOBENEWSWIRE
NMPA Approves Promega MSI Kit as KEYTRUDA Companion Diagnostic
03 Feb 2026 //
PHARMIWEB
Merck Announces 2025 Financial Results, Pipeline Progress
03 Feb 2026 //
PHARMIWEB

Market Place
Sourcing Support